Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-589,443
Closed -$28.9M 4555
2026
Q1
$28.9M Buy
+589,443
New +$27.4M 0.07% 234
2024
Q4
Sell
-136,601
Closed -$5.54M 2628
2024
Q3
$5.54M Buy
+136,601
New +$5.14M 0.03% 419
2023
Q4
Sell
-89,325
Closed -$3.38M 2526
2023
Q3
$3.38M Buy
89,325
+81,166
+995% +$3.31M 0.03% 425
2023
Q2
$332K Buy
+8,159
New +$337K ﹤0.01% 1562
2022
Q1
Sell
-30,050
Closed -$1.24M 3306
2021
Q4
$1.24M Buy
+30,050
New +$1.13M 0.01% 948
2020
Q3
Sell
-43,156
Closed -$1.12M 2024
2020
Q2
$1.12M Buy
+43,156
New +$1.15M 0.03% 513

Other funds holding EXC

HRT Financial's EXC Position: Q2 2026 in Review

HRT Financial sold out of Exelon (EXC) in Q2 2026, closing a stake of 589,443 shares — an estimated $28.9M sold.

HRT Financial first reported a position in EXC in Q2 2020 and held it in 6 quarters. The position peaked at $28.9M in Q1 2026. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • HRT Financial reported no remaining Exelon position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 589,443 Exelon shares in Q2 2026, an estimated $28.9M.
  • HRT Financial first reported a position in Exelon in Q2 2020 and held it in 6 quarters.
  • HRT Financial's Exelon position peaked at $28.9M in Q1 2026.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.